SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-134477
Filing Date
2021-04-27
Accepted
2021-04-27 17:16:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d179359ddefa14a.htm DEFA14A 16085
2 GRAPHIC g179359page038.jpg GRAPHIC 271850
3 GRAPHIC g179359page039.jpg GRAPHIC 149817
  Complete submission text file 0001193125-21-134477.txt   598132
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39425 | Film No.: 21860054
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences